These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

829 related articles for article (PubMed ID: 9469236)

  • 81. Citalopram in the treatment of depression.
    Parker NG; Brown CS
    Ann Pharmacother; 2000 Jun; 34(6):761-71. PubMed ID: 10860138
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Developments in the drug treatment of panic disorder: what is the place of the selective serotonin reuptake inhibitors?
    Westenberg HG
    J Affect Disord; 1996 Sep; 40(1-2):85-93. PubMed ID: 8882918
    [TBL] [Abstract][Full Text] [Related]  

  • 83. The place for the tricyclic antidepressants in the treatment of depression.
    Boyce P; Judd F
    Aust N Z J Psychiatry; 1999 Jun; 33(3):323-7. PubMed ID: 10442787
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Clinical implications of the pharmacology of serotonin reuptake inhibitors.
    Warrington SJ
    Int Clin Psychopharmacol; 1992 Oct; 7 Suppl 2():13-9. PubMed ID: 1484174
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Interaction studies with moclobemide.
    Zimmer R; Gieschke R; Fischbach R; Gasic S
    Acta Psychiatr Scand Suppl; 1990; 360():84-6. PubMed ID: 2248085
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Antidepressant-induced hepatotoxicity.
    Lucena MI; Carvajal A; Andrade RJ; Velasco A
    Expert Opin Drug Saf; 2003 May; 2(3):249-62. PubMed ID: 12904104
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Moclobemide versus tranylcypromine in the treatment of depression.
    Rossel L; Moll E
    Acta Psychiatr Scand Suppl; 1990; 360():61-2. PubMed ID: 2248075
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Direct comparison of tricyclic and serotonin-reuptake inhibitor antidepressants in randomized head-to-head trials in acute major depression: Systematic review and meta-analysis.
    Undurraga J; Baldessarini RJ
    J Psychopharmacol; 2017 Sep; 31(9):1184-1189. PubMed ID: 28633600
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Overview of antidepressants currently used to treat anxiety disorders.
    Feighner JP
    J Clin Psychiatry; 1999; 60 Suppl 22():18-22. PubMed ID: 10634351
    [TBL] [Abstract][Full Text] [Related]  

  • 90. St. John's wort: a new alternative for depression?
    Josey ES; Tackett RL
    Int J Clin Pharmacol Ther; 1999 Mar; 37(3):111-9. PubMed ID: 10190758
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Problems with currently available antidepressants.
    Gumnick JF; Nemeroff CB
    J Clin Psychiatry; 2000; 61 Suppl 10():5-15. PubMed ID: 10910012
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Antidepressants for people with epilepsy and depression.
    Maguire MJ; Marson AG; Nevitt SJ
    Cochrane Database Syst Rev; 2021 Apr; 4(4):CD010682. PubMed ID: 33860531
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Quality of treatment: what do new antidepressants offer?
    Lader M
    Int Clin Psychopharmacol; 1995 Mar; 10 Suppl 1():5-9. PubMed ID: 7622812
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Comparative efficacy and acceptability of antidepressants in Parkinson's disease: a network meta-analysis.
    Liu J; Dong J; Wang L; Su Y; Yan P; Sun S
    PLoS One; 2013; 8(10):e76651. PubMed ID: 24098546
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Sexual side effects of antidepressants: a review.
    Margolese HC; Assalian P
    J Sex Marital Ther; 1996; 22(3):209-17. PubMed ID: 8880654
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Anxiety disorders: a review of tricyclic antidepressants and selective serotonin reuptake inhibitors.
    Zohar J; Westenberg HG
    Acta Psychiatr Scand Suppl; 2000; 403():39-49. PubMed ID: 11019934
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Side-effect profile of fluoxetine in comparison with other SSRIs, tricyclic and newer antidepressants: a meta-analysis of clinical trial data.
    Brambilla P; Cipriani A; Hotopf M; Barbui C
    Pharmacopsychiatry; 2005 Mar; 38(2):69-77. PubMed ID: 15744630
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Antidepressant use in the elderly: the role of pharmacodynamics and pharmacokinetics in drug safety.
    Sultana J; Spina E; Trifirò G
    Expert Opin Drug Metab Toxicol; 2015 Jun; 11(6):883-92. PubMed ID: 25736834
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Empirically Supported Use of Psychiatric Medications in Adolescents and Adults with IBD.
    Thorkelson G; Bielefeldt K; Szigethy E
    Inflamm Bowel Dis; 2016 Jun; 22(6):1509-22. PubMed ID: 27167571
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Benefits and risks of pharmacotherapy for dysthymia: a systematic appraisal of the evidence.
    De Lima MS; Hotopf M
    Drug Saf; 2003; 26(1):55-64. PubMed ID: 12495364
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 42.